Loading...
•
Dec 31, 2025
Sotera Health Q4 2025 Earnings Report
Sotera Health reported solid fourth-quarter 2025 revenue growth and higher profitability, with improved net income and stable adjusted margins year-over-year.
Key Takeaways
Sotera Health generated fourth-quarter 2025 net revenues of 303441000 dollars, up 4.6% year-over-year, with net income of 34847000 dollars compared to 12323000 dollars in the prior year. Adjusted EBITDA increased to 157037000 dollars, while adjusted EBITDA margin was 51.8%.
Q4 net revenues increased 4.6% year-over-year to 303441000 dollars.
Net income rose to 34847000 dollars from 12323000 dollars in Q4 2024.
Adjusted EBITDA grew 2.7% year-over-year to 157037000 dollars.
Net leverage ratio improved to 3.2x as of year-end 2025.
Revenue by Segment
Forward Guidance
For 2026, the company expects net revenue growth of 5.0% to 6.5% and Adjusted EBITDA growth of 5.5% to 7.0% on a constant currency basis.
Positive Outlook
- Net revenues projected between 1233000000 and 1251000000 dollars.
- Adjusted EBITDA projected between 632000000 and 641000000 dollars.
- Estimated 100 basis point foreign currency benefit.
- Adjusted EPS guidance range of 0.93 to 1.01.
- Continued focus on margin expansion and cash flow generation.
Challenges Ahead
- Exposure to foreign currency fluctuations.
- Interest expense projected between 135000000 and 145000000 dollars.
- Tax rate applicable to Adjusted Net Income expected between 27.0% and 29.0%.
- Ongoing regulatory and litigation risks related to EO facilities.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...